Cost-Effectiveness of Vismodegib Verse Standard of Care Therapy in the Treatment of Locally-Advanced or Symptomatic Metastatic Basal Cell Carcinoma in Hungary – A Global Cost-Effectiveness Model Adaptation
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2270
https://www.valueinhealthjournal.com/article/S1098-3015(14)04200-4/fulltext
Title :
Cost-Effectiveness of Vismodegib Verse Standard of Care Therapy in the Treatment of Locally-Advanced or Symptomatic Metastatic Basal Cell Carcinoma in Hungary – A Global Cost-Effectiveness Model Adaptation
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04200-4&doi=10.1016/j.jval.2014.08.2270
First page :
A633
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1724